1 59-291 Section 2, Lecture 4 Adrenergic Receptor Agonists -termed sympathomimetic 3 Groups: Direct-acting Indirect-acting mixed-acting Direct-acting Subdivided.

Slides:



Advertisements
Similar presentations
Sympathetic Drugs. Stress and The Adrenal Glands.
Advertisements

Conversion of Amino Acids to Specialized Products.
Drugs Affecting Peripheral Nervous System #2. Fight or Flight versus the Parasympathetic Pig.
Pharmacology 101 Abdelkader Ashour, Ph.D. 7 th Lecture.
Pharmacology-1 PHL 211 Fourteenth Lecture By Abdelkader Ashour, Ph.D. Phone:
Yacoub Irshaid MD, PhD, ABCP Department of Pharmacology
Adrenergic agonists Samuel Aguazim (MD).
DOPAMINE DOPAMINE: Used in renal failure with shock. Acts on dopamine, alpha 1 and beta 1 receptors. Low dose activates dopamine-1 receptors in the renal.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 17 Adrenergic Agonists.
Joseph De Soto MD, PhD, FAIC
Cholinergic agonists & Cholinergic antagonists
Drugs Affecting the Sympathetic Nervous System
Autonomic Nervous System
Mosby items and derived items © 2011, 2007, 2004 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 18 Adrenergic Drugs.
Adrenergic Agonists (Sympathomimetics)
Adrenergic Agonist By: Dr.ALTWIJRY. Adrenergic Drugs  Adrenergic receptors are divided into two major types according to drug potency on the receptors.
Adrenergic Drugs  Adrenergic receptors are divided into two major types according to drug potency on the receptors  Alpha-(α-) adrenergic receptors,
Sympathomimetics (continue)
SYMPATHOMIMETIC DRUGS
BIOC Dr. Tischler Lecture 42 – April 14, 2005 ENDOCRINOLOGY: CATECHOLAMINES.
Adrenergic agonists Samuel Aguazim (MD).
AUTONOMIC SYSTEMS AND DRUGS-2
Autonomic drugs: Adrenoceptor Agonists and Sympathomimetics
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 17 Adrenergic Drugs.
Adrenergic Receptor Antagonists Excessive sympathetic activity is characteristic of a number of pathological states including: Hypertension Angina pectoris.
Synthesis & Release of Neurotransmitters
1 Adrenergic Receptor Agonists Termed sympathomimetic drugs Divided into three groups Direct-acting agonists –Catecholamines –Noncatecholamines Indirect-acting.
Chapter 19 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
HuBio 543 September 26, 2007 Neil M. Nathanson K-536A, HSB Adrenergic Agonists &Other Sympathomimetics.
Adrenergic agonist drugs
Andrenergic Agonists. Overview Adrenergic drugs stimulate the same receptors as norepinephrine and epinephrine. Drugs that stimulated the adrenergic receptors.
Part 4 Adrenoceptor agonists §1. ,  receptor agonists §2.  receptor agonists §3.  receptor agonists.
Actions of epinephrine:
Lecture 11b Clinical uses of adrenergic agonists.
23 كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، كانون الثاني، 1623 كانون الثاني، كانون الثاني، كانون الثاني،
Neurotransmitters: Monoamines
AUTONOMIC NS DRUGS (2) Dr: Samah Gaafar Al-shaygi.
Lecture 7 Summary –Adrenalin (α & β): ↑ systolic BP & slight ↓diastolic BP –NA: (α & β1) ↑ systolic & diastolic BP + Reflex bradycardia –Isoproterenol.
Sympathomimetics Review 28 February :25 PM.
Sympathetic Nervous System.
Adrenergic agonists Saja Hamed, Ph.D.
Dr. Laila M. Matalqah Ph.D. Pharmacology PHARMACOLOGY OF ANS part 2 General Pharmacology M212.
17 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، آذار، آذار، 1617 آذار، 16.
Copyright © 2012, 2009, 2006, 2003 by Saunders, an imprint of Elsevier Inc. 1 Chapter 18 ADRENERGIC AGONISTS AND ADRENERGIC BLOCKERS.
Phenylephrine Phenylephrine Phenylephrine is a direct-acting, synthetic adrenergic drug that binds primarily to α receptors ( favors α 1 receptors over.
SYMPATHOMIMETIC AGENTS
Adrenergic Agonists and Adrenergic Blockers
PRESSORS & ANTIHYPERTENSIVES Luis R. Sauceda-Cerda, MD PGY-4.
Adrenergic Agonists.
Department of Pharmacology
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
على قدر الهدف يكون الانطلاق.
ADRENERGIC MEDICATIONS (sympathomimetic drugs)
Adrenergic agonist: PHARMACOLOGY OF SNS.
Adrenergic Agonists Produce their effects by activating adrenergic receptors Adrenergic receptors are Alpha 1 Alpha 2 Beta 1 Beta 2 Dopamine.
SYMPATHETIC NERVOUS SYSTEM
Adrenergic drugs.
Pharmacological actions of cathecholamines
Sympathomimetics Domina Petric, MD.
School of Pharmacy, University of Nizwa
Sympathomimetic drugs
Adrenergic agonists.
Characteristics of Adrenergic Drugs (p. 291)
Sympathomimetic drugs (Adrenergic agonists) Pharmacology Department
Adrenergic Agonists.
Adrenergic Acting Drugs Pharmaceutical Medicinal Chemistry-I
Adrenergic System And Drugs  Adrenergic transmission  Adrenergic receptor  Adrenergic drugs  Therapeutic classification of adrenergic drugs  Pharmacological.
Adrenergic agonists ILOS
Adrenergic Antagonist
Adrenergic Agonists.
Presentation transcript:

Section 2, Lecture 4 Adrenergic Receptor Agonists -termed sympathomimetic 3 Groups: Direct-acting Indirect-acting mixed-acting Direct-acting Subdivided into: -catecholamines -non catecholamines

2 Catecholamines Naturally occuring- NE, E, dopamine Synthetic- isoproterenol and dobutamine These are rapidly inactivated by 2 enzymes found in the gut and liver and in many other tissues: monoamine oxidase (MAO) and catechol- o-methyltransferase (COMT); low oral bioavailabilities and short t ½ therefore must be administered parenterally.

3 Mechanisms and Effects Catecholamines differ wrt affinities and specificities for the receptors Draw relative response vs log [Catecholamine] plots for the agonists in the box.

4

5

6 Sys, Dias., MeanArt. P

7 Adverse effects: -excessive vasoconstriction leading to ischemia -reduces blood flow to vital organs such as kidneys; cause excessive cardiac stimulation leading to myocardial ischemia ar arrythmias -  -adrenergic agonists: hyperglycemia undesirable in diabetics Indirect-Acting Amphetamine- induces the release of NE Cocaine-prevents reuptake of NE

8 Mixed-Acting: the name says it all! activate both α and  receptors Ephedrine and Pseudoephedrine vasoconstriction via  1 receptors; useful as nasal decongestants; via  bronchodilate Adverse effects: tachycardia, hypertension, urinary retention